These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3144890)

  • 21. Antigen related to cell proliferation in malignant gliomas recognized by a human monoclonal antibody.
    Kokunai T; Tamaki N; Matsumoto S
    J Neurosurg; 1990 Dec; 73(6):901-8. PubMed ID: 2230972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening a hybridoma producing a specific monoclonal antibody to HLA-A24+Bw4 antigen by cytotoxicity inhibition assay.
    Hiroishi S; Kaneko T; Arita J
    Tissue Antigens; 1987 Feb; 29(2):120-2. PubMed ID: 3299870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monoclonal antibodies to the antigens of human HeLa tumor cells].
    Malakhova IV; Khizhniakova TM; Novokhatskiĭ AS
    Tsitologiia; 1986 May; 28(5):537-44. PubMed ID: 3526672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human-human hybridoma producing monoclonal antibodies against colorectal cancer-associated antigens.
    Borup-Christensen P; Erb K; Ditzel H; Nielsen B; Larsen JK; Svehag SE; Jensenius JC
    APMIS; 1990 Aug; 98(8):674-84. PubMed ID: 2206514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells.
    Carrel S; De Tribolet N; Gross N
    Eur J Immunol; 1982 Apr; 12(4):354-7. PubMed ID: 6954072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of human glioma-associated antigen by rat monoclonal antibody raised against syngeneic rat glioma cells.
    Saya H; Masuko T; Kokunai T; Yagita H; Ijichi A; Taomoto K; Tamaki N; Matsumoto S; Hashimoto Y
    J Neurosurg; 1986 Oct; 65(4):495-502. PubMed ID: 3760959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human monoclonal antibodies specific for the tumour associated Thomsen-Friedenreich antigen.
    Dahlenborg K; Hultman L; Carlsson R; Jansson B
    Int J Cancer; 1997 Jan; 70(1):63-71. PubMed ID: 8985092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alloimmunization with cultured human stomach cancer cell lines and the establishment of human-human hybridomas producing monoclonal antibodies.
    Koyama K; Akiyama K; Kawahara H; Egashira A; Murakami H
    Jpn J Cancer Res; 1990 Oct; 81(10):967-70. PubMed ID: 2121682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies.
    Helfand SC; Hank JA; Gan J; Sondel PM
    Cell Immunol; 1996 Jan; 167(1):99-107. PubMed ID: 8548851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher cytolytic efficiency of an IgG2 alpha than of an IgG1 monoclonal antibody reacting with the same (or spatially close) determinant on a human high-molecular-weight melanoma-associated antigen.
    Imai K; Pellegrino MA; Wilson BS; Ferrone S
    Cell Immunol; 1982 Sep; 72(2):239-47. PubMed ID: 6185235
    [No Abstract]   [Full Text] [Related]  

  • 31. Multiplicity of newly established monoclonal antibodies against hepatocellular carcinomas.
    Ohzu K; Hasegawa K; Yamauchi K; Obata H
    J Gastroenterol Hepatol; 1990; 5(6):601-7. PubMed ID: 1966596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of human melanoma-associated cell surface antigens by hybridoma monoclonal antibodies.
    Burk MW; Saxton RE; Mann BD; Morton DL
    Surgery; 1983 Jul; 94(1):84-90. PubMed ID: 6857516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of monoclonal antibodies to Sp2/O-Ag 14 myeloma cells.
    Zlotnik H; Miranda MT; Kozek WJ; Borrero GL; Lavergne JA; Díaz AM
    P R Health Sci J; 1988 Apr; 7(1):31-4. PubMed ID: 3375421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effector immune mechanisms in cancer.
    Lotzová E
    Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
    [No Abstract]   [Full Text] [Related]  

  • 35. Monoclonal antibodies point to carbohydrate structures as tumour-associated antigens.
    Feizi T
    Med Biol; 1983 Jun; 61(3):144-6. PubMed ID: 6195491
    [No Abstract]   [Full Text] [Related]  

  • 36. Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.
    Bullard DE; Bigner DD
    J Neurosurg; 1985 Jul; 63(1):2-16. PubMed ID: 2409248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones.
    Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L
    Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neutron capture using boronated monoclonal antibody directed against tumor-associated antigens.
    Barth RF; Johnson CW; Wei WZ; Carey WE; Soloway AH; McGuire J
    Cancer Detect Prev; 1982; 5(3):315-23. PubMed ID: 7151064
    [No Abstract]   [Full Text] [Related]  

  • 39. Development of a monoclonal antibody against a tumor-associated antigen.
    Peng WW; Bressler JP; Tiffany-Castiglioni E; de Vellis J
    Science; 1982 Feb; 215(4536):1102-4. PubMed ID: 7063842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cytotoxic monoclonal antibody produced from a human urinary bladder carcinoma cell line (TSGH-8301).
    Ma CP; Yeh MY; Yu DS; Jiang SY; Wang CC; Chang SY; Han SH
    Proc Natl Sci Counc Repub China B; 1988 Apr; 12(2):101-8. PubMed ID: 3054971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.